MYM Nutraceuticals Inc. vs. My Marijuana Inc.

Gerade gefunden - bei meiner Suche - nach noch unentdecken Marijuana-Werten.

MYM


Was haltet ihr von der Aktie - gehandelt nur in Kanada und Deutschland ( Frankfurt ).
PS: Leider noch nicht in USA :-(
Die Homepage ist wohl grad in Arbeit lt. letzter Pressemeldung. Die alte Homepage
liefert zwar nur ein paar Daten - klingt aber interessant.....was meint ihr dazu ??
Könnte man einen Einstieg wagen ??? Aktie ist fast noch nicht gelaufen......

Meinungen ?
Könnte das ein künftiger "Ten- oder 20-Bagger" sein  ??

NEWS RELEASE
MYM ANNOUNCES NEW CORPORATE BRAND AND LOGO
Vancouver,  B.C.,  Oct  26,  2016  –  
MYM  Nutraceuticals  Inc.
,  (CSE:
MYM
)  (the  “Company”  or  “
MYM
”)  is  
pleased to announce its new organizational identity for MYM Nutraceuticals.   The rebranding represents
both the evolution of the company and its vision for the future.   The new look is an important part of
MYM
Nutraceuticals
strategy for 2017 as it helps the company show the world the transformational change it has
embarked on, as it reaches out and engages more actively with the many growers, manufacturers, patients,
doctors and consultants currently involved in the health care and medical cannabis industry.
The new name, logo, and design will provide the company with a more consistent brand identity around
the world that speaks to all languages and regions.  Signaling our emergence in the global community
united by a common purpose, our new visual identity will deliver that message with a corporate look that
is soft, colourful and approachable.  The inspiration behind the new logo comes from 3 components:
1) the green is a symbol for environmentalism and sustainability; 2) the sun represents growth; and 3)
The element of the leaf is the true essence of
MYM
’s product line.  The leafs were also shaped to represent
a circular pattern and the company’s pursuit for growth in it’s community. The company’s acronym and
name was position below the icon for perfect balance, the “y” was intentionally left below the underline
to symbolize the roots of it’s business model:  
THE HEALTH CARE INDUSTRY.
Jonathan Fiteni
,
CEO
commented, “I am delighted to announce the new organizational identity for
MYM
Nutraceuticals
.  We are excited to finally show case our new name with a logo design that simply represents
our company more honestly.  Our new design demonstrates clear visual change without losing the meaning,
or recognition of
MYM Nutraceuticals
original brand and logo, (formally My Marijuana Inc.), that has been
built up over two years to be a licensed marijuana producer of cannabis based nutraceutical products. “
In the next few months the management team will be working to finish the new website which will
showcase the new products and services being offered under the new brand.  We will be introducing, for
the first time, the new Corporate business plan which will clearly outline the management team’s direction
for the company over the next 5 years and beyond.  
ABOUT MYM.
MYM Nutraceuticals Inc., (MYM)
is a public company trading on the Canadian Stock Exchange, (CSX), who’s primary focus,
is developing high-end organic medicinal supplements and Hemp Topical products with an interest in the development of high
density farming facilities and technologies.  
MYM
has identified the potential market of providing turn-key facilities which derive revenue from land and equipment lease fee’s
while also providing consulting services to its tenants of high density grow operations.  Further to this business model is the
potential for manufacturing facilities for tenants who would specialize in the area of Organic herb and Hemp based products.
Through  it’s  wholly  owned  subsidiary  the  objective  is  to  be  a  leader  in  land  development  servicing  the  new  age  farming  
entrepreneur in Canada and abroad
 

Hab ein wenig Research betrieben - für mich - bei MYM.
Ist wohl etwas wage zur Zeit das Bild vom MYM, aber sollte hier halbwegs eine
Zielrichtung vom Managment vorliegen, und der kommende 5-Jahres-Business-Plan, der
demnächst vorgelegt, vorgestellt werden soll, ins "Schwarze" Treffen und was
noch wichtiger ist - auch umgesetzt werden/werden können,
könnte MYM bei z.Zt. ca. 55 Mio Akiten - durchaus in 1 Jahr ab Heute - oder vielleicht
auch früher - Richtung  2-3  Can Dollar marschieren.

Alles meine Meinung und meine persönliches Kursziel.
Denke ich werde die nächsten Tage, evtl. schon morgen,  versuchen einzusteigen in die Aktie, und werde diese dann über die im Jahr 2017 stattfindende Neue Gesetzgebung + Liberalisierung in Kanada halten.
Aufgrund der dann sehr heufigen  PR + Fernsehberichte + Print und Social Media Kampgnen dürfte die Aktie dann eine Boom erleben in 2017. Ähnlich wie viele andere Cannabis-Aktien in Kanada + USA.

Ich melde mich zu MYM hin und wieder - wenn sich was neues tut.
CU

 

Cannabis-Aktien Portfolio das grad in USA für Furore sorgt...... ??

Nur leider ist MYM Aktie nur in in CAN + DEU handelbar im Moment und deshalb
wohl noch nicht auf dem Radar der Anleger in USA - sonst wäre die Aktie
wohl bereits heute bei 50 Cent und nicht bei 5 Cent !!

Aber vielleicht kommt MYM ja bald mit einem Listing an der OTCBB um die Ecke!
Mal sehen...  

Nur noch wenige Tage zu den US-Wahlen - viele Investoren stehen wohl in den Startlöchern,
und irgendwie sagt mir auch mein Gefühl - sollten es fast allen US-Staaten schaffen
MJ zu legalisieren egal in welcher Form - wird der Markt und die gelisteten Börsenunternehmen
von Geld nur so zugeschüttet.....! Es wird mächtig Boom machen m. M. nach.....!!
x
x


Hier ein Artikel der genau das verdeutlicht.:

SAN FRANCISCO, Nov 3 (Reuters) - Marijuana private equity investor Privateer Holdings has raised $40 million in convertible debt ahead of next week's elections, with pot legalization on the ballot in nine U.S. states.

Several investors rushed to place their funds, while others held back to wait for the election results.
Of the nine states that will vote on Tuesday on legalizing medical or recreational marijuana, California ranks as the most important. The most populous U.S. state is considering allowing recreational adult use. If the measure passes, it is expected to legitimize part of a multi-billion-dollar black market and open new opportunities for companies ranging from software to pot delivery.
Financial services firm Cowen and Co forecasts a $50 billion U.S. market in a decade, up from $6 billion in legal sales today. U.S. law prohibits marijuana but federal agencies so far have limited their enforcement effort for companies which follow local laws in states that have legalized pot.
Seattle-based Privateer is one of several funds and investment companies targeting marijuana businesses. It said investors were divided on when to make their moves.
"Most of the potential lead investors wanted to wait until after next Tuesday to invest," Chief Executive Brendan Kennedy said in an interview. Others were ready to invest, but it was difficult to agree on how to value Privateer, with the outcome of the state votes unclear. The presidential race was a secondary issue, he added.
"This is a way to sort of take capital from investors without having to negotiate the price," he said. Privateer hopes to raise $100 million in the next round, including the notes.
The valuation of the company will be set when the round closes, and convertible note holders will get a 15 percent discount when they get equity in Privateer, he said.

The company plans to put more than half of the round in companies outside the United States, including Canada and potentially Australia, he said.
(Reporting by Peter Henderson; Editing by Leslie Adler)

http://www.cnbc.com/2016/11/03/...-40-mln-on-eve-of-us-elections.html  

eine weitere Abstimmtung über die Vollständige Lagalisierung von MJ in ganz Kanada an !!

Also Medienpräsenz ist hier wohl die ganzen nächsten Monate in einem
sehr hohen Ausmaß gegeben. Man wird die Wörter Cannabis, Marijuana, USA, Kanada
Legalisierung  - bald auch im Privaten Umfeld wohl sehr hoft höhen :-)
Dann sind wir - die sich frühzeitig sich positioniert haben an der Börse - bereits die Gewinner.
 

Wenn der Kurs irgendwann bei 50 Cent  oder sogar 1 Euro steht,
ist bestimmt hier mehr los hier im Board bei MYM.......und ich bereits lange dabei :-)  

http://thecse.com/sites/default/files/01_012617_PPAnnouncement.pdf  

http://www.stockhouse.com/news/press-releases/...nnounces-acquisition

http://thecse.com/en/listings/life-sciences/mym-nutraceuticals-inc  

Seit 5 Monaten bin ich hier am kaufen...Still und heimlich.
Hab das was jetzt kommt , mir gewünscht,. Die Geduld zahlt sich hier noch kräftig aus.
Egal ob 60 Cent oder 2 Euro , ich nehme alles gerne hin :-)
Dazu noch die News von heute!!  

Bin gespannt ob wir heute wieder Richtung Norden drehen!  

....werden wir früher oder später erreichen.
Geduld zahlt sich aus - 20 % - oder auch mal 20 % runter an einem Tag -
ist halt bei diesen Werten normal. Lasst euch nicht rausschütteln  ( meine Meinung ).
Ich bleibe drin - und statt 0,16 Euro - freue ich mich schon bald auf 1,60 Euro :-)
Denke bis März/April nicht unmöglich - wenn die zu erwartenden News,
die nächsten Wochen - Schlag auf Schlag - so kommen wie ich denke !
Bei 1 Euro mal drüber nachdenken - den Einsatz rauszunehmen - Rest bleibt bis
1,60 Euro oder xxxx Euro........ mal sehen..........je nach Einschätzung und Momentum
zum jeweiligen Zeitpunkt.  

Hat Jemand Infos wie es mit der Zulassung steht?  

MYM CLOSES ACQUISITION OF INSPECTION-STAGE LICENSED PRODUCER APPLICATION


Vancouver, B.C., February 22, 2017 – MYM Nutraceuticals Inc. (CSE:MYM) (the “Company” or “MYM”) is pleased to announce that  it has completed its acquisition of a majority interest in Sublime Culture Inc. (“Sublime”) and its inspection-stage application to become a Licensed Producer of medical cannabis.  As announced on February 1, MYM will supply funding and resources to build out Sublime’s production facility in preparation for inspection by Health Canada.

Pursuant to a Share Exchange Agreement between MYM and Sublime’s two primary shareholders, in exchange for 250,000 Class A shares in the capital of Sublime, MYM issued 490,000 MYM shares to 9076484 Canada Inc., and in exchange for 260,000 Class A Sublime shares from CannaTechnology Inc., MYM issued 510,000 shares to that company.  MYM now owns 51% of the outstanding shares of Sublime, and a commensurate 51% interest in the Licensed Producer application.

As announced earlier this month, this is a vital acquisition for MYM and its shareholders.  Obtaining a production license under the Access to Cannabis for Medical Purposes Regulations will significantly accelerate the launch of the Company’s innovative brand of cannabis-infused nutraceutical products. MYM will also be able to leverage Sublime’s expertise and connections in Eastern Canada, as well as bring on key personnel to facilitate future growth.

A tour of the facility and other potential assets was conducted over the past weekend as the MYM team met with all the engineers, contractors and team members who will be responsible for running the facility once it is completed.  Key benchmarks with respect to maximizing production space and the purchase of the property were established, and plans are now underway to stage the build-out of the entire building with the inclusion of a roof-top greenhouse that will maximize the total production canopy to 36,000 square feet.  MYM management intends to pursue the purchase of the land and, upon successful inspection and issuance of a license, start the additional build-outs, thereby allowing the Company to own up to 90% of Sublime Culture Inc. and 100% of the production facility.  This will allow MYM to meet the demands it expects from its ever-growing client patient list and create even more shareholder value.

Jonathan Fiteni, CEO, commented:  “With the closing of this deal, MYM now possesses a majority interest in a late-stage Licensed Producer application.  We are excited about working with Sublime to build out the facility in Laval and prepare for inspection.  The opportunity in Quebec is much larger than we anticipated.  Becoming a Licensed Producer will allow us to move aggressively on our plans to create exciting new products and engage potential patients who are currently using the dispensary model.  Being able to fast-track our ability to produce quality cannabis products is a game-changer for us and our shareholders.  I am very proud of our team for the countless hours spent searching for the right partner and the new talent that we expect will join our growing company.”

ABOUT MYM
MYM Nutraceuticals Inc. (CSE:MYM) is a public company trading on the Canadian Stock Exchange whose primary focus is developing high-end organic medicinal marijuana supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market.
MYM has identified the potential market in providing extraction and processing services to large and independent ACMPR farming operations looking to produce high quality plant extracts using top quality C02 extraction equipment and customized formulations.  Further to this business model is the ability to provide these services on-site via mobile convoy.

ON BEHALF OF THE BOARD

“Jonathan Fiteni”

Jonathan Fiteni
CEO and Director
Telephone: 778-317-7932
Email: info@mymarijuana.ca

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
 

 

 

MYM z.Zt. mit ca. 13 Mio Euro.
Hier wäre ja Potential mit Faktor  x 20 drin bei MYM.
0,20 Euro x 20  = 4 Euro.

Trifft sich fast mit meiner "persönlichen" Einschätzung das wir in 2017 - wenn die Lizenz kommt,
wovon ich ausgehe - 5 Euro bei MYM sehen werden. Bin schon auf die nächsten News gespannt.
Denke MYM hat noch einiges in der Pipeline die nächsten Monate.  

 

 

Neue Hochs werden noch bald genug kommen.
Die nächsten 2 - 3 News die MYM bringt - werden zeigen wohin die Reise geht :-)
Ich bleib dabei und bin optimistisch.  

Es gibt News!  

http://www.finanzen.net/nachricht/aktien/...enfuehrer-HempMed-5365899  

 

 

Denke das waren zum Schluß, "Sell on good NEWS" , am Freitag.

Viele haben ihr Pos. vor dem Wochenende mal glatt gestellt, und wollen schauen wie es
nun weitergeht.
Ich glaub fest daran, das nächste Woche hier bei MYM endlich mal wieder grün wird,
und wir sogar wieder neue Hochs machen werden.

Sollte MYM die Lizensen für Kanada bekommen, das Netzwerk weiter ausbauen können, durch
Übernahmen etc., ist eine Marktbewertung von 200-300 Mio Can-Dollar durchaus
möglich in 2017.
Würde einem Kursziel von 3-5 Can-Dollar entsprechen in 2017.

Was meint ihr - wie seht ihr das ganze ??

 

Theoretisch sehe ich MYM auch sehr positiv für die Zukunft.  Ich verstehe nur nicht, dass der Kurs so absolut Null auf die letzten News reagiert.. Schade eigentlich...evtl. der Trump Effekt?
Habe aber so noch etwas nachgelegt gerade weil ich sehr optimistisch bin was die Zukunft betrifft... Es dauert halt noch etwas :)